Skip to content
OpenCapital
Get started

LivaNova LIVN Options forfeited/expired (in dollars per share)

Options forfeited/expired (in dollars per share) at other companies

Baxter International logo
Baxter InternationalBAX
$54.86-15.9%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice.

The official record: LivaNova’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's options forfeited/expired (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's options forfeited/expired (in dollars per share)?
LivaNova (LIVN) reported options forfeited/expired (in dollars per share) of $79.49 in Q4 2025.
How has LivaNova's options forfeited/expired (in dollars per share) changed year-over-year?
LivaNova's options forfeited/expired (in dollars per share) increased by 3.6% year-over-year, from $76.76 to $79.49.
What does options forfeited/expired (in dollars per share) mean?
The weighted-average exercise price per share for all stock options that were either forfeited or expired during the reporting period. This metric assists in evaluating the historical pricing of equity awards that did not result in share issuance.